We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-18.19%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$13.6B
AUM Growth
+$1.76B
Cap. Flow
+$4.28B
Cap. Flow %
31.58%
Top 10 Hldgs %
12.23%
Holding
3,376
New
988
Increased
735
Reduced
602
Closed
941

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$170M
2
MPC icon
Marathon Petroleum
MPC
+$162M
3
MSFT icon
Microsoft
MSFT
+$149M
4
CVX icon
Chevron
CVX
+$147M
5
META icon
Meta Platforms (Facebook)
META
+$131M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$100M
2
ZTS icon
Zoetis
ZTS
+$78.9M
3
CERN
Cerner Corp
CERN
+$74M
4
SUI icon
Sun Communities
SUI
+$68.8M
5
MDLZ icon
Mondelez International
MDLZ
+$68.2M

Sector Composition

Rank Sector Weight
1 Technology 18.59%
2 Financials 11.55%
3 Healthcare 11.46%
4 Energy 9.75%
5 Industrials 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PPTA
2026
Perpetua Resources
PPTA
$2.18B
$77K ﹤0.01%
+23,176
New +$83.2K
HGEN
2027
DELISTED
HUMANIGEN, INC.
HGEN
$77K ﹤0.01%
+43,770
New +$98.3K
SPRY icon
2028
ARS Pharmaceuticals
SPRY
$572M
$76K ﹤0.01%
+17,866
New +$62.3K
VKTX icon
2029
Viking Therapeutics
VKTX
$3.91B
$76K ﹤0.01%
26,323
-2,360
-8% -$5.84K
TCRR
2030
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$76K ﹤0.01%
+26,180
New +$64.6K
ADAP
2031
DELISTED
Adaptimmune Therapeutics
ADAP
$75K ﹤0.01%
+43,966
New +$75.5K
CMCT
2032
Creative Media & Community Trust
CMCT
$8.49M
– –
0
– –
ICAD
2033
DELISTED
iCAD Inc
ICAD
$75K ﹤0.01%
+18,729
New +$71.4K
VHC icon
2034
VirnetX Holding Corp
VHC
$53.6M
$75K ﹤0.01%
+3,184
New +$88.7K
NAGE
2035
Niagen Bioscience
NAGE
$260M
$75K ﹤0.01%
+44,771
New +$87.6K
NMTR
2036
DELISTED
9 Meters Biopharma
NMTR
$75K ﹤0.01%
+14,390
New +$136K
SPD icon
2037
Simplify US Equity PLUS Downside Convexity ETF
SPD
$104M
$74K ﹤0.01%
+2,780
New +$79.8K
CRDF icon
2038
Cardiff Oncology
CRDF
$62.4M
$73K ﹤0.01%
+33,038
New +$55.3K
HNRG icon
2039
Hallador Energy
HNRG
$697M
$73K ﹤0.01%
+13,515
New +$65.3K
HRTG icon
2040
Heritage Insurance Holdings
HRTG
$891M
$73K ﹤0.01%
+27,573
New +$118K
RYLD icon
2041
Global X Russell 2000 Covered Call ETF
RYLD
$1.37B
$73K ﹤0.01%
+3,530
New +$76.9K
STIM icon
2042
Neuronetics
STIM
$126M
$73K ﹤0.01%
+22,685
New +$65.9K
UXIN
2043
Uxin Ltd
UXIN
$334M
$73K ﹤0.01%
+1,730
New +$104K
CBD
2044
DELISTED
Companhia Brasileira de Distribuicao
CBD
$73K ﹤0.01%
23,691
-119,216
-83% -$506K
DRD
2045
DRDGold
DRD
$1.8B
$72K ﹤0.01%
+12,323
New +$91.4K
FXH icon
2046
First Trust Health Care AlphaDEX Fund
FXH
$1.04B
$72K ﹤0.01%
697
-961
-58% -$103K
GVI icon
2047
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
$72K ﹤0.01%
680
-396
-37% -$42K
HIVE
2048
HIVE Digital Technologies
HIVE
$754M
$72K ﹤0.01%
+24,149
New +$140K
RAIN
2049
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$72K ﹤0.01%
+12,922
New +$44.4K
USX
2050
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$72K ﹤0.01%
+26,966
New +$84K
80 81
82
83 84

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q2 2022 Portfolio in Review

As of Q2 2022, Qube Research & Technologies (QRT) held 3,376 positions worth $13.6B, up 15% from $11.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.28B of net new capital in Q2 2022, opening 988 new positions and adding to 735 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 541,117 shares worth $148M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Verizon, an estimated $100M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2022 buy was Berkshire Hathaway Class B: 541,117 shares worth $148M.
  • Qube Research & Technologies (QRT) added most to Marathon Petroleum in Q2 2022, an estimated $162M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2022 reduction was Verizon, cutting an estimated $100M.
  • Qube Research & Technologies (QRT) fully exited Cerner Corp in Q2 2022, selling an estimated $74M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 12% of its $13.6B portfolio in Q2 2022.
  • Qube Research & Technologies (QRT) opened 988 new positions and closed 941 in Q2 2022.
  • Qube Research & Technologies (QRT)'s portfolio value rose 15% quarter-over-quarter to $13.6B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.